Drug Shortage Report for ANGELIQ

Last updated on 2019-03-19 History
Report ID 73486
Drug Identification Number 02268825
Brand name ANGELIQ
Common or Proper name drospirenone and estradiol
Company Name BAYER INC
Market Status MARKETED
Active Ingredient(s) DROSPIRENONE ESTRADIOL
Strength(s) 1.0MG 1.0MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 28's
ATC code G03FA
ATC description PROGESTOGENS AND ESTROGENS IN COMBINATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-03-11
Actual start date
Estimated end date 2019-04-17
Actual end date 2019-03-18
Shortage status Resolved
Updated date 2019-03-19
Company comments Product is now available to market.
Health Canada comments
Tier 3 Status No
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-03-19 English Compare
v9 2019-03-18 French Compare
v8 2019-03-18 English Compare
v7 2019-03-12 English Compare
v6 2019-02-27 French Compare
v5 2019-02-27 English Compare
v4 2019-02-16 English Compare
v3 2019-01-24 French Compare
v2 2019-01-24 French Compare
v1 2019-01-24 English Compare

Showing 1 to 10 of 10